Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 6,044.00
-1.00 (-0.02%)
Apr 17, 2026, 3:30 PM JST
TYO:4530 Revenue
In the fiscal year ending February 28, 2026, Hisamitsu Pharmaceutical Co. had annual revenue of 163.02B JPY with 4.50% growth. Hisamitsu Pharmaceutical Co. had revenue of 48.51B in the quarter ending February 28, 2026, with 8.39% growth.
Revenue
163.02B
Revenue Growth
+4.50%
P/S Ratio
2.61
Revenue / Employee
58.24M
Employees
2,799
Market Cap
425.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 163.02B | 7.02B | 4.50% |
| Feb 28, 2025 | 156.01B | 14.30B | 10.09% |
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Toho Holdings | 1.54T |
| Eisai | 808.19B |
| Sumitomo Pharma | 453.40B |
| Towa Pharmaceutical | 269.92B |
| Sawai Group Holdings | 200.68B |
| Tsumura & Co. | 189.50B |
| Nippon Shinyaku | 166.05B |
| Mochida Pharmaceutical | 111.92B |
Hisamitsu Pharmaceutical Co. News
- 3 months ago - Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO - Reuters